CHANGES IN PLASMA VASCULAR ENDOTHELIAL GROWTH FACTOR LEVEL AFTER INTRAVITREAL INJECTION OF BEVACIZUMAB, AFLIBERCEPT, OR RANIBIZUMAB FOR DIABETIC MACULAR EDEMA

PURPOSE: The aim of this study was to investigate the changes in plasma vascular endothelial growth factor (VEGF) level depending on the severity of diabetic retinopathy (DR) or diabetic macular edema (DME) and after intravitreal injection of bevacizumab, aflibercept, or ranibizumab for treatment of...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirano, Takao, Toriyama, Yuichi, Iesato, Yasuhiro, Imai, Akira, Murata, Toshinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Retina 2018
Materias:
Original Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110374/
https://www.ncbi.nlm.nih.gov/pubmed/29280940
http://dx.doi.org/10.1097/IAE.0000000000002004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110374/
https://www.ncbi.nlm.nih.gov/pubmed/29280940
http://dx.doi.org/10.1097/IAE.0000000000002004

Ejemplares similares